LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES

BACKGROUND: Approximately 5% of melanoma pts develop LMDz. There are essentially no models of LMDz available for therapeutic development. Here we report, the in-vitro & in-vivo culturing of CSF-CTCs. METHODS: CSF-CTCs were detected by the Veridex CellSearch® System. Cell-free DNA and cell-associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Vincent, Evernden, Brittany, Kenchappa, Rajappa, Puskas, John, Caceres, Gisela, Ryzhova, Elena, Smalley, Inna, Etame, Arnold, Sahebjam, Solmaz, Magliocco, Anthony, Smalley, Keiran, Forsyth, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213446/
http://dx.doi.org/10.1093/noajnl/vdz014.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213446/
http://dx.doi.org/10.1093/noajnl/vdz014.026

Ejemplares similares